<DOC>
	<DOCNO>NCT02068287</DOCNO>
	<brief_summary>Beta adrenergic system , over-activated septic shock patient , key modulator inflammatory response . Experimental work demonstrate Esmolol , highly selective beta-1 blocker , reduces heart rate regulate inflammatory response . A recent mono centric , double blind , randomize clinical work septic shock patient show Esmolol administration safe reduces effectively heart rate . However sparse data 1 ) regional micro-circulation , 2 ) inflammation modulation human resuscitate septic shock patient treat esmolol .</brief_summary>
	<brief_title>Esmolol Effects Heart Inflammation Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>septic shock patient follow definition Surviving Sepsis Campaign femoral central venous catheter thermodilution monitor fluid optimization cardiac index &gt; 3 l/min/m2 Heart Rate &gt; 100 /min Cardiogenic shock Bradycardia History Severe Asthma Indications esmolol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Septic Shock</keyword>
	<keyword>Hemodynamic</keyword>
	<keyword>Inflammatory status</keyword>
	<keyword>Beta adrenergic modulation</keyword>
	<keyword>Esmolol</keyword>
</DOC>